FAKTOR-OPTIONSSCHEIN - POLE GROU | Market Closed - Börse Stuttgart 07:04:21 2024-06-13 am EDT | ||
| 13.21 EUR | -2.72% |
|
| Current month | +10.36% | ||
| 1 month | +4.59% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
POLYPEPTIDE GROUP AG
Latest news about POLYPEPTIDE GROUP AG
More news
| Date | Price | Change |
|---|---|---|
| 24-06-13 | 13.21 | -2.72% |
| 24-06-12 | 13.58 | +4.62% |
| 24-06-11 | 12.98 | +1.72% |
| 24-06-10 | 12.76 | -2.89% |
| 24-06-07 | 13.14 | -5.81% |
Delayed Quote Börse Stuttgart
Last update June 13, 2024 at 07:04 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | POLYPEPTIDE GROUP AG |
| Issuer | Morgan Stanley |
| WKN | MG1ERA |
| ISIN | DE000MG1ERA1 |
| Date issued | 2024-04-03 |
| Strike | 21.64 CHF |
| Maturity | Unlimited |
| Parity | 0.87 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 15.65 € |
|---|---|
| Lowest since issue | 9.05 € |
| Spread | 0.36 € |
| Spread % | 2.68% |
Company Profile
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Sector
-
Consensus: PolyPeptide Group AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
33.71
EUR
Average target price
25.12
EUR
Spread / Average Target
-25.47%
- Stock Market
- Certificates
- Certificat
